The Primary Care Companion for CNS Disorders

CME Institute

Home | About Us | Mission Statement | All CME Activities | MyCME | CME Facebook | CME Twitter

JCP

Home | About JCP | Subscribe | Archive | Information for Authors | Information for Reviewers | Information for Advertisers | CNS Job Market | Customer Service | JCP Facebook | JCP Twitter

PCC

Home | About PCC | Register | Archive | Information for Authors | Information for Reviewers | PCC Facebook | PCC Twitter

Help

FAQ | About Psychiatrist.com | Terms of use | Privacy policy

magnifying glass for search

  • magnifying glass for search
  • Advanced Search

Login

Login  
Login | Login Help | Register | Subscribe
Register | Elerts

Quick Links

Font: A | A | A

Top

Purchase PDF

Vol 12, No 2
Table of Contents

Facebook ShareShare

twitter shareTweet This

envelope iconEmail a link

Related ►

Related Articles

[X]

<p class="frontmatter-fieldnotes disclaimernew" style="margin-bottom:15px;">This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s <a href="/pages/termsofuse.aspx" target="_blank">Terms & Conditions</a>.</p> <div id="x09l00830yel">
<div class="story">
<p class="ltrs-br-ltr-br-title">Quetiapine Treatment for Delirious Mania in a Military Soldier</p>
<p class="ltrs-br-ltr-br-body-text"><span class="bold">To the Editor:</span> Delirious mania is a severe psychiatric syndrome characterized by acute onset of delirium, excitement, and psychosis. It was initially described by Calmeil in 1832 as an uncommon but life-threatening psychosis with extreme hyperactivity and mounting fear fading to stuporous exhaustion.<span class="superscript">1</span> Its reported mortality rate reached 75%.<span class="superscript">2</span></p>
<p class="ltrs-br-ltr-br-body-text">The modern literature pertaining to clinical characteristics and treatment outcomes of delirious mania is sparse, consisting mainly of case series.<span class="superscript">3</span> There have been many controversies about proper nomenclature, with terms such as <span class="italic">lethal catatonia</span> and <span class="italic">malignant catatonia</span> proposed along with <span class="italic">delirious mania</span>.<span class="superscript">4</span> It is thought of as an uncommon syndrome, although it may be underrecognized since several authors have suggested that as many as 15%–20% of all acutely manic patients show signs of delirium.<span class="superscript">4</span> Patients with this syndrome experience significant morbidity and a high mortality rate without treatment.<span class="superscript">5</span></p>
<p class="ltrs-br-ltr-br-body-text">Delirious mania is marked by acute onset of the excitement, grandiosity, emotional lability, delusions, and insomnia characteristic of mania and the disorientation and altered consciousness characteristic of delirium.<span class="superscript">6</span> Many patients give a history of alcohol, cannabis, and hallucinogenic use.<span class="superscript">4</span></p>
<p class="ltrs-br-ltr-br-body-text">Bond<span class="superscript">7</span> outlined 6 criteria that distinguish delirious mania: (1) acute onset, (2) presence of hypomania or mania, (3) developing signs and symptoms of delirium, (4) past history of mania or depression, (5) family history of affective disorder, and (6) responsivity to treatment for mania.</p>
<p class="ltrs-br-ltr-br-body-text">Karmacharya et al<span class="superscript">3</span> recently suggested that the definitive treatment for this condition is electroconvulsive therapy (ECT). In cases in which ECT is not available, high-dose benzodiazepines should be used. Clozapine, quetiapine, lithium, and valproate cannot be considered first-line treatments, and these medications take an unacceptably long time to work even when helpful; typical antipsychotics and anticholinergic drugs should be avoided.</p>
<p class="ltrs-br-ltr-br-body-text">There is now, however, no clear consensus on which clinical features are associated with delirious mania or which treatments are effective.<span class="superscript">3</span> We report a case of delirious mania in which remission was successfully achieved with quetiapine 300 mg/d.</p>
<p class="ltrs-br-ltr-br-body-text">&nbsp;</p>
<p class="ltrs-br-ltr-br-body-text"><span class="bold-italic">Case report.</span> Mr A, a 21-year-old man, is serving as a naval sergeant after withdrawing from his university temporarily. He did not have either medical or psychiatric past history.</p>
<p class="ltrs-br-ltr-br-body-text">In March 2008, when he called his mother from his military unit, his speech had low tone, no special content, and few words compared to usual. The next day, he felt as if telepathic messages were blowing over him at his every breath. He heard a voice of the woman whom he loved one-sidedly when he was a middle school student. The contents of the telepathy were “Brother,” “I love you!” and “See you at [a specific time],” with use of a dialect. He felt funny and good when he heard the voice say, “Truth to tell, I have waited for you!” and “I have seen you!” He believed that he could send messages telepathically if he shut up and did not move his tongue. He spent much of his time lying down and exchanging telepathy with her. When he did not receive replies to his telepathic messages, he experienced hearing his thought being sent from him over and over, which made him angry. He slept for only 1 or 2 hours per day and did not feel hungry because he focused on exchanging telepathic messages all night. He was hesitant about telling anyone about his ability. When he felt warm or an ache in his leg, he thought that the feeling suggested a transmission from her. He thought that he could share his imagination with her when he laughed for no reason. He decided to name this phenomenon “cosympathy.” Three days after his initial telephone call to his mother, he woke up at about 6:00 <span class="smallcaps">am</span> and tried to leave his military unit to go home. His random talking led to his being sent to the navy medical center. In the navy medical center, he talked incoherently, stating that she loved him too, that he could also exchange telepathy with his mother, and that he thought of himself as God.</p>
<p class="ltrs-br-ltr-br-body-text">The next day, he was hospitalized at the closed psychiatric ward at Pusan National University Hospital, Busan, South Korea, for psychiatric evaluation and management. Brain magnetic resonance imaging, electroencephalogram, and laboratory examination for toxicology were done to evaluate organic causes, but there were no abnormal findings. A day later, the second day of his stay, he showed restricted affect with reduction of speech volume, and he only answered repeatedly, “I do not know” and “No.” He was disoriented about place and person. He showed impaired immediate memory, not replying to repeated questions. His thought content was somewhat grandiose, and he rambled on concrete subjects about equalized education, public education, and praying to God. That evening, he became suddenly paranoid and excited, asking, “Where am I?” and “Why am I here?” while talking on the telephone. On the third day of his stay, his attitude during interview was very aggressive, and he demanded his discharge with a loud voice. Treatment with quetiapine 200 mg/d was started under the suspicion of the possible presence of bipolar disorder and brief psychotic disorder (diagnoses that were subsequently ruled out according to <span class="italic">DSM-IV</span> criteria). His attitude was continuously aggressive, and his mood was slightly expansive in the appearance and words.</p>
<p class="ltrs-br-ltr-br-body-text">After 1 week of hospitalization, his mood became euthymic and his psychotic symptoms were relieved. He was amnesic about the specific period (from returning to his unit after holiday through talking on the telephone on the second day of hospitalization). He was discharged from the hospital 29 days after admission. He is now serving in the navy and is being followed up in the outpatient clinic once a month. He is maintaining euthymic mood and normal thoughts with quetiapine 200 mg/d. He is performing his duty as a driver well.</p>
<p class="ltrs-br-ltr-br-body-text">&nbsp;</p>
<p class="ltrs-br-ltr-br-body-text">In the case presented here, onset of symptoms was very acute, and the patient showed elevated mood, very talkative speech, increased speech tone, and the grandiose feature that he could communicate with telepathy. Until the second day of hospitalization, he was confused and disoriented, with delirious mentality that showed impaired immediate memory. Also, from that evening, he became excited with paranoid delusion, acting out verbally. Accordingly, such a course as this suggests the possibility of delirious mania, judging from the comorbid condition of manic symptoms and delirious state.</p>
<p class="ltrs-br-ltr-br-body-text">Delirious mania shows variable symptoms, from distinctive symptoms of delirious mania such as incontinence, inappropriate toileting, and denudativeness to manic or psychotic symptoms such as labile affect, auditory hallucination, hypersexuality, severe insomnia, and pressured speech. The diagnosis and treatment of delirious mania may be difficult since the severity of symptoms may also be diverse. Our case reported here indicates that the usual mood-stabilizing doses of quetiapine can be a useful therapy for delirious mania, a syndrome very tricky to diagnose and treat.</p>
<p class="ltrs-br-ltr-br-references-head"><span class="smallcaps">References</span></p>
<p class="references-references-text-1-9"> 1. Calmeil LF. <span class="italic">Dictionnaire de medicine; our repertoire general des sciences medicales considerees sous le rapport theorique et pratique</span>. 2nd ed. Paris, France: Bechet; 1832.</p>
<p class="references-references-text-1-9"> 2. Bell L. On a form of disease resembling some advanced stage of mania and fever. <span class="italic">Am J Insanity</span>. 1849;6:97–127.</p>
<p class="references-references-text-1-9"> 3. Karmacharya R, England ML, Ongür D. Delirious mania: clinical features and treatment response. <span class="italic">J Affect Disord</span>. 2008;109(3):312–316. <span class="pubmed-crossref"><a href="http://dx.doi.org/10.1016/j.jad.2007.12.001">doi:10.1016/j.jad.2007.12.001</a> <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=18191210&dopt=Abstract">PubMed</a></span></p>
<p class="references-references-text-1-9"> 4. Fink M. Delirious mania. <span class="italic">Bipolar Disord</span>. 1999;1(1):54–60. <span class="pubmed-crossref"><a href="http://dx.doi.org/10.1034/j.1399-5618.1999.10112.x">doi:10.1034/j.1399-5618.1999.10112.x</a> <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11256658&dopt=Abstract">PubMed</a></span></p>
<p class="references-references-text-1-9"> 5. Friedman RS, Mufson MJ, Eisenberg TD, et al. Medically and psychiatrically ill: the challenge of delirious mania. <span class="italic">Harv Rev Psychiatry</span>. 2003;11(2):91–98. <span class="pubmed-crossref"><a href="http://dx.doi.org/10.1080/10673220303960">doi:10.1080/10673220303960</a> <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12868509&dopt=Abstract">PubMed</a></span></p>
<p class="references-references-text-1-9"> 6. Fink M, Taylor MA. The many varieties of catatonia. <span class="italic">Eur Arch Psychiatry Clin Neurosci</span>. 2001;251(suppl 1):I8–I13. <span class="pubmed-crossref"><a href="http://dx.doi.org/10.1007/PL00014200">doi:10.1007/PL00014200</a> <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11776271&dopt=Abstract">PubMed</a></span></p>
<p class="references-references-text-1-9"> 7. Bond TC. Recognition of acute delirious mania. <span class="italic">Arch Gen Psychiatry</span>. 1980;37(5):553–554.<span class="pubmed-crossref"> <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=6103694&dopt=Abstract">PubMed</a></span></p>
<p class="ltrs-br-ltr-br-author"><span class="bold">Woo Young Jung, MD</span></p>
<p class="ltrs-br-ltr-br-author"><span class="bold">Byung Dae Lee, MD, PhD</span></p>
<p class="ltrs-br-ltr-br-author"><a href="mailto:psyleebd@gmail.com" target="_blank">psyleebd@gmail.com</a></p>
<p class="ltrs-br-ltr-br-endmatter-fieldnotes"><span class="bold-italic">Author affiliations: </span>Medical Research Institute and Department of Psychiatry, Pusan National University Hospital, Busan, South Korea. </p>
<p class="ltrs-br-ltr-br-endmatter-fieldnotes"><span class="bold-italic">Potential conflicts of interest: </span>None reported. </p>
<p class="ltrs-br-ltr-br-endmatter-fieldnotes"><span class="bold-italic">Funding/support:</span> None reported.</p>
<p class="ltrs-br-ltr-br-endmatter-fieldnotes"><span class="bold-italic">Published online:</span> April 29, 2010 (<span class="doi">doi:10.4088/PCC.09l00830yel</span>).</p>
<p class="ltrs-br-ltr-br-copyright-doi"><span class="italic">Prim Care Companion J Clin Psychiatry 2010;12(2):e1–e2</span></p>
<p class="ltrs-br-ltr-br-copyright-doi"><span class="italic">© Copyright 2010 Physicians Postgraduate Press, Inc.</span></p>
</div>
</div>
Manage Subscriptions
/_layouts/images/ReportServer/Manage_Subscription.gif
/PCC/article/_layouts/ReportServer/ManageSubscriptions.aspx?list={ListId}&ID={ItemId}
0x80
0x0
FileType
rdl
350
Manage Data Sources
/PCC/article/_layouts/ReportServer/DataSourceList.aspx?list={ListId}&ID={ItemId}
0x0
0x20
FileType
rdl
351
Manage Shared Datasets
/PCC/article/_layouts/ReportServer/DatasetList.aspx?list={ListId}&ID={ItemId}
0x0
0x20
FileType
rdl
352
Manage Parameters
/PCC/article/_layouts/ReportServer/ParameterList.aspx?list={ListId}&ID={ItemId}
0x0
0x4
FileType
rdl
353
Manage Processing Options
/PCC/article/_layouts/ReportServer/ReportExecution.aspx?list={ListId}&ID={ItemId}
0x0
0x4
FileType
rdl
354
Manage Cache Refresh Plans
/PCC/article/_layouts/ReportServer/CacheRefreshPlanList.aspx?list={ListId}&ID={ItemId}
0x0
0x4
FileType
rdl
355
View Report History
/PCC/article/_layouts/ReportServer/ReportHistory.aspx?list={ListId}&ID={ItemId}
0x0
0x40
FileType
rdl
356
View Dependent Items
/PCC/article/_layouts/ReportServer/DependentItems.aspx?list={ListId}&ID={ItemId}
0x0
0x4
FileType
rsds
350
Edit Data Source Definition
/PCC/article/_layouts/ReportServer/SharedDataSource.aspx?list={ListId}&ID={ItemId}
0x0
0x4
FileType
rsds
351
View Dependent Items
/PCC/article/_layouts/ReportServer/DependentItems.aspx?list={ListId}&ID={ItemId}
0x0
0x4
FileType
smdl
350
Manage Clickthrough Reports
/PCC/article/_layouts/ReportServer/ModelClickThrough.aspx?list={ListId}&ID={ItemId}
0x0
0x4
FileType
smdl
352
Manage Model Item Security
/PCC/article/_layouts/ReportServer/ModelItemSecurity.aspx?list={ListId}&ID={ItemId}
0x0
0x2000000
FileType
smdl
353
Regenerate Model
/PCC/article/_layouts/ReportServer/GenerateModel.aspx?list={ListId}&ID={ItemId}
0x0
0x4
FileType
smdl
354
Manage Data Sources
/PCC/article/_layouts/ReportServer/DataSourceList.aspx?list={ListId}&ID={ItemId}
0x0
0x20
FileType
smdl
351
Load in Report Builder
/PCC/article/_layouts/ReportServer/RSAction.aspx?RSAction=ReportBuilderModelContext&list={ListId}&ID={ItemId}
0x0
0x2
FileType
smdl
250
Edit in Report Builder
/_layouts/images/ReportServer/EditReport.gif
/PCC/article/_layouts/ReportServer/RSAction.aspx?RSAction=ReportBuilderReportContext&list={ListId}&ID={ItemId}
0x0
0x4
FileType
rdl
250
Edit in Report Builder
/PCC/article/_layouts/ReportServer/RSAction.aspx?RSAction=ReportBuilderDatasetContext&list={ListId}&ID={ItemId}
0x0
0x4
FileType
rsd
250
Manage Caching Options
/PCC/article/_layouts/ReportServer/DatasetCachingOptions.aspx?list={ListId}&ID={ItemId}
0x0
0x4
FileType
rsd
350
Manage Cache Refresh Plans
/PCC/article/_layouts/ReportServer/CacheRefreshPlanList.aspx?list={ListId}&ID={ItemId}&IsDataset=true
0x0
0x4
FileType
rsd
351
Manage Data Sources
/PCC/article/_layouts/ReportServer/DataSourceList.aspx?list={ListId}&ID={ItemId}
0x0
0x20
FileType
rsd
352
View Dependent Items
/PCC/article/_layouts/ReportServer/DependentItems.aspx?list={ListId}&ID={ItemId}
0x0
0x4
FileType
rsd
353
Compliance Details
javascript:commonShowModalDialog('{SiteUrl}/_layouts/itemexpiration.aspx?ID={ItemId}&List={ListId}', 'center:1;dialogHeight:500px;dialogWidth:500px;resizable:yes;status:no;location:no;menubar:no;help:no', function GotoPageAfterClose(pageid){if(pageid == 'hold') {STSNavigate(unescape(decodeURI('{SiteUrl}'))+'/_layouts/hold.aspx?ID={ItemId}&List={ListId}'); return false;} if(pageid == 'audit') {STSNavigate(unescape(decodeURI('{SiteUrl}'))+'/_layouts/Reporting.aspx?Category=Auditing&backtype=item&ID={ItemId}&List={ListId}'); return false;} if(pageid == 'config') {STSNavigate(unescape(decodeURI('{SiteUrl}'))+'/_layouts/expirationconfig.aspx?ID={ItemId}&List={ListId}'); return false;}}, null); return false;
0x0
0x1
ContentType
0x01
898
Document Set Version History
javascript:SP.UI.ModalDialog.ShowPopupDialog('{SiteUrl}/_layouts/DocSetVersions.aspx?List={ListId}&ID={ItemId}')
0x0
0x0
ContentType
0x0120D520
330
Send To other location
javascript:GoToPage('{SiteUrl}/_layouts/docsetsend.aspx?List={ListId}&ID={ItemId}')
0x0
0x0
ContentType
0x0120D520
350

Information Links

Terms of Use | Privacy Policy | Information for Authors (JCP) | Information for Authors (PCC) | Reprints and Permissions | CNS Job Market | Information for Advertisers | Media Relations | PPP COVID-19 Statement

Help

Contact us | Unsubscribe from Elerts | Customer Service | FAQ | About JCP | About PCC | About Psychiatrist.com

Our Family of Sites

Psychiatrist.com | The Journal of Clinical Psychiatry | The Primary Care Companion | The CME Institute | Strong Veterans
Anonymous